Treatment decision-making among patients with metastatic prostate cancer: Impact of decision locus of control on functional outcomes and decision satisfaction.
Frank A SchumacherIrene B HelenowskiZequn SunLaura B OswaldBrian D GonzalezKelvin A MosesJames T BenningAlicia K MorgansPublished in: Prostate cancer and prostatic diseases (2023)
mPC patients reporting SDM had better physical functioning at 4 months than physician- or patient-directed decision-making, suggesting measurable benefit from patient involvement in decision-making. Future investigations of these associations in larger, more diverse populations can further clarify these previously unmeasured benefits of patient engagement in treatment decisions.
Keyphrases
- decision making
- prostate cancer
- case report
- end stage renal disease
- chronic kidney disease
- ejection fraction
- small cell lung cancer
- physical activity
- emergency department
- squamous cell carcinoma
- primary care
- newly diagnosed
- social media
- radical prostatectomy
- peritoneal dialysis
- combination therapy
- adverse drug
- current status
- patient reported
- genetic diversity